Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anton Uryvaev"'
Publikováno v:
Chemotherapy.
Introduction: Fluorouracil (5-FU) pharmacokinetics are variable, leading to risk of toxicity in some patients and under-dosing in others. Therapeutic drug monitoring (TDM) of 5-FU was shown to reduce toxicity and increase efficacy. This study assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9455f1de28171a971eefecfb99a4382f
https://pubmed.ncbi.nlm.nih.gov/36273438
https://pubmed.ncbi.nlm.nih.gov/36273438
Publikováno v:
Medical oncology (Northwood, London, England). 35(3)
Immunotherapy plays an important role in cancer treatment. Biomarkers that can predict response, including tumor-infiltrating lymphocytes (TILs), are in the spotlight of many studies. This cohort study was designed to evaluate the role of CD4+ and CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d10f3c8aaab58f3601e0775f0ed3559
https://pubmed.ncbi.nlm.nih.gov/29388007
https://pubmed.ncbi.nlm.nih.gov/29388007
Publikováno v:
Breast cancer research and treatment. 153(1)
Angiosarcoma of the breast represents 1 % of all soft tissue breast tumors. With breast-conserving therapy (BCT) as standard in the last three decades, a new type of angiosarcoma has been reported: post-irradiation angiosarcoma (PIAS). A recent study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b529c0af5824d393e7a09a9a9e8c78f
https://pubmed.ncbi.nlm.nih.gov/26206321
https://pubmed.ncbi.nlm.nih.gov/26206321